Aurora Cannabis Inc. (TSE:ACB) shares have retraced a considerable 26% in the last month, reversing a fair amount of their solid recent performance. Instead of being rewarded, shareholders who have already held through the last twelve months are now sitting on a 25% share price drop.
Although its price has dipped substantially, there still wouldn’t be many who think Aurora Cannabis’ price-to-sales (or “P/S”) ratio of 1x is worth a mention when the median P/S in Canada’s Pharmaceuticals industry is similar at about 0.7x. Although, it’s not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
Check out our latest analysis for Aurora Cannabis
